NM_016203.4(PRKAG2):c.1052-4A>G AND not provided

Germline classification:: Uncertain significance (3 submissions)
Last evaluated:: Jun 1, 2022
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000788238.14

Allele description [Variation Report for NM_016203.4(PRKAG2):c.1052-4A>G]

NM_016203.4(PRKAG2):c.1052-4A>G

Gene:

PRKAG2:protein kinase AMP-activated non-catalytic subunit gamma 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7q36.1

Genomic location:

Preferred name:

NM_016203.4(PRKAG2):c.1052-4A>G

HGVS:

NC_000007.14:g.151570229T>C
NG_007486.2:g.312003A>G
NM_001040633.2:c.920-4A>G
NM_001304527.2:c.677-4A>G
NM_001304531.2:c.329-4A>G
NM_001363698.2:c.680-4A>G
NM_016203.4:c.1052-4A>GMANE SELECT
NM_024429.2:c.329-4A>G
LRG_430t1:c.1052-4A>G
LRG_430:g.312003A>G
NC_000007.13:g.151267315T>C
NG_007486.1:g.312002A>G
NM_016203.3:c.1052-4A>G

Links:

dbSNP: rs977597576

NCBI 1000 Genomes Browser:

rs977597576

Molecular consequence:

NM_001040633.2:c.920-4A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001304527.2:c.677-4A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001304531.2:c.329-4A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001363698.2:c.680-4A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_016203.4:c.1052-4A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_024429.2:c.329-4A>G - intron variant - [Sequence Ontology: SO:0001627]

Observations:

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000927287	Blueprint Genetics	criteria provided, single submitter (Blueprint Genetics Variant Classification Scheme)	Uncertain significance (Jun 10, 2017)	germline	clinical testing	Citation Link,
SCV001812242	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (May 15, 2019)	germline	clinical testing	Citation Link,
SCV004156982	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Uncertain significance (Jun 1, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000927287

Blueprint Genetics

criteria provided, single submitter

(Blueprint Genetics Variant Classification Scheme)

Uncertain significance
(Jun 10, 2017)

germline

clinical testing

Citation Link,

SCV001812242

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(May 15, 2019)

germline

clinical testing

Citation Link,

SCV004156982

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Uncertain significance
(Jun 1, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	1	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Blueprint Genetics, SCV000927287.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From GeneDx, SCV001812242.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Located in a region that tolerates variation and lacks pathogenic variants

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From CeGaT Center for Human Genetics Tuebingen, SCV004156982.10

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

PRKAG2: PM2, BP4

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine